A 2011 review conducted by the International Agency for Research on Cancer concluded that studies on the impact of price increases on aggregate demand find average price elasticity rates of about 0.4 in high-income countries, with most estimates from the US and UK falling into a relatively narrow range between 0.2 and 0.6
The survey also found that in the past 30 days, 33% of respondents admitted to vaping on at least three occasions, which is classified as "regular use." This is significantly higher than the national average of 10% quoted in the report, for regular vaping among young people
Miravitlles has received speaker or consulting fees from AstraZeneca, Bial, Boehringer Ingelheim, Chiesi, Cipla, CSL Behring, Laboratorios Esteve, Gebro Pharma, Kamada, GlaxoSmithKline, Grifols, Menarini, Mereo Biopharma, Novartis, pH Pharma, Palobiofarma SL, Rovi, TEVA, Spin Therapeutics, Verona Pharma and Zambon, and research grants from Grifols
A., Pittilo, R